Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Captor Therapeutics Spolka Akcyjna (CTX.WA)

Warsaw - Warsaw Delayed Price. Currency in PLN
177.00-2.00 (-1.12%)
At close: 05:00PM CET
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in PLN

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 1/28/2023
Current
9/30/20226/30/20223/31/202212/31/2021
Market Cap (intraday)
737.76M575.20M494.89M660.48M742.21M
Enterprise Value
653.36M479.09M391.22M540.27M622.00M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/A
Price/Sales (ttm)
168.19126.78118.43243.99274.18
Price/Book (mrq)
7.285.324.284.975.58
Enterprise Value/Revenue
141.54431.62328.48521.50486.32
Enterprise Value/EBITDA
-20.00-70.04-49.71-60.34-69.03

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 34.07%
S&P500 52-Week Change 3-8.47%
52 Week High 3188.00
52 Week Low 3102.50
50-Day Moving Average 3171.84
200-Day Moving Average 3150.11

Share Statistics

Avg Vol (3 month) 33.12k
Avg Vol (10 day) 33.87k
Shares Outstanding 54.17M
Implied Shares Outstanding 6N/A
Float 82.91M
% Held by Insiders 145.32%
% Held by Institutions 115.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Sep 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-863.30%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.62M
Revenue Per Share (ttm)1.11
Quarterly Revenue Growth (yoy)-11.40%
Gross Profit (ttm)3.25M
EBITDA -32.55M
Net Income Avi to Common (ttm)-40.28M
Diluted EPS (ttm)-7.89
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)92.7M
Total Cash Per Share (mrq)22.24
Total Debt (mrq)8.3M
Total Debt/Equity (mrq)8.19
Current Ratio (mrq)8.62
Book Value Per Share (mrq)24.32

Cash Flow Statement

Operating Cash Flow (ttm)-26.4M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement